Advertisement

Topics

Companies Related to "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" [Most Relevant Company Matches] - Page: 4 RSS

17:14 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" found in our extensive corporate database of over 50,000 company records.

Showing "Study BuEAM Conditioning Autologous Stem Cell Transplantation ASCT" Companies 76–100 of 2,100+

Relevant

Novocell, Inc

Novocell’s goal is to develop a renewable source of specialized cells that can be used to treat chronic cellular diseases. To achieve this goal, Novocell is uniquely positioned to exploit human stem cell engineered product opportunities using its proprietary cell encapsulation technology. Combined with Novocell's expertise in cell transplantation, these technologies will allow large numbers of p...


Applied StemCell, Inc.

Applied StemCell Inc. (ASC) is a fast growing biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Using our proprietary TARGATT™ gene modification technology, we make site-specific Knockin mouse, rat and human cell line models fast and efficient for pharmaceutical and academic community. Based on our Proprietary Technologies, we focus o...

Cell Line Genetics, Inc.

Cell Line Genetics, Inc. is a leading provider of multi-species Quality Assurance services and products for the Stem Cell and Regenerative Medicine market. Focusing on embryonic, adult and induced pluripotent stem cells, CLG provides a variety of multispecies QA services for research, preclinical and clinical studies. Headquartered in Madison, Wisco...


Forever Labs

Forever Labs is the first company to bank young adult stem cells, so you can live a healthier and longer life. Research on stem cells suggest that as you age, you lose stem cells and the ones that remain become damaged and less effective. As a longevity company and an educational force in stem cell research, Forever Labs is transforming the healthcare indu...

Life Stem Genetics Inc.

Life Stem Genetics (“LSG”) is a progressive health care company that focuses on healing with a patient’s own “Stem Cells”. Stem Cells for years have been known to heal a variety of ailments successfully and now it is being offered as an efficient and painless way to treat many different illnesses ranging from orthopedic Injuries, neurolog...

Capricor, Inc.

Los Angeles-based Capricor is a biotechnology company that aims to create powerful, yet easy-to-administer cardiac stem cell treatments to regenerate the heart and improve its function. Its products strive to bring improved quality of life to the millions of people suffering from heart disease. Capricor is the only stem cell company working to develop and ...

Elsevier and Cell Press

Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the scientific community it serves. Cell Press primary research journals include the flagship journal Cell, as well as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, S...

StemBioSys Inc.

StemBioSys, Inc., a privately held, San Antonio-based biomedical company, manufactures and develops innovative, advanced stem cell technologies to meet the promise of regenerative medicine in a surging global market. Its patented and proprietary technology platforms — licensed from the University of Texas Board of Regents — overcome key obstacles...

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the stem cell assets of Geron Corporation, which was completed on October 1, 2013. That acquisition includes Geron’s entire cell therapy intellectual property portfolio, existing co...

Beta-Cell

Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the highly specialized endocrine cells located in pancreatic islets and responsible for producing insulin. Beta-Cell has an advanced pre-clinical xeno-transplantation program based on its proprietary techno...

ES Cell International Party Limited

ES Cell International Pte Ltd is a regenerative medicine company aiming to be a world leading provider of products and technologies derived from human embryonic stem (hES) cells. ES Cell International controls significant platform technology due to its intellectual property and know-how in the area of hES cells and their directed differentiation.ES Cell International is one of 10 groups whose hES ...

Fate Therapeutics, Inc.

Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem cell (iPSC) technology to develop stem cell modulators, small molecule or biologic compounds that guide cell fate for therapeutic purposes. The Company's award-winning, proprietary iPSC technology platform incorporates the most advanced viral, small molecule and protein reprogramming methods and offer...

Genea Stem Cells Pty Ltd

Genea Stem Cells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Stem Cells Pty Ltd is governed by the same strong ethical principles and corporate governance practices. Genea Stem Cells is located in Sydney, Australia and has been supplying commercial stem cell solutions for s...

Gamida Cell Ltd.

Gamida Cell is developing expanded stem cell therapies for the treatment of such illnesses as blood cancers, cardiac disease and diabetes. The Company is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regeneration power of an ample body of therapeutic stem cells

Accellta

Accellta develops, manufactures and markets a range of revolutionary solutions for better affordability and quality of stem cell culturing. Accellta's technologies are the result of over 15 years of pioneering research and development at the Stem Cell Center in the Technion’s Rappaport Faculty of Medicine. Accellta is a subsidiary of the Alfred Mann I...

Medistem Inc.

Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The company's lead product, the endometrial regenerative cell (ERC), is a "universal donor" stem cell being developed for critical limb ischemia and congestive heart failure. A pu...

Vitrolife AB (publ)

The fourth of the total of twelve patients included in the USA study for STEEN Solution™, and which enables sales approval in the important USA market, has now received a transplant. The first transplantation was carried out in September and four transplantations have thus now been carried out at four centres. A fifth centre, Duke University, has been ...

Ocata Therapeutics, Inc.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocataâ...

Ocata Therapeutics, Inc.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of regenerative ophthalmology therapeutics. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocataâ...

Creative Medical Technologies

Creative Medical Technologies, Inc. (CMT) and its affiliate Creative Medical Health, Inc. (CMH) are clinical stage biotechnology companies specializing in cutting edge stem cell technology in the areas of urology, cardiovascular disease, orthopedics and type 2 diabetes. In addition to their work with LA BioMed, CMH and CMT have ongoing relationships with s...

Verastem, Inc.

Verastem, Inc. (NASDAQ: VSTM) is a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: F...

Cord Blood America, Inc.

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing numbe...

MediStem Laboratories

Medistem Laboratories is an innovative biotechnology company committed to the creation and commercialization of advanced medical therapies based on non-controversial adult stem cells. Medistem's corporate mission is to transform these stem cells into valuable medical treatments. The Company's business strategy calls for the establishment of a series of clinics and laboratories around the world to ...

Kadimastem

Kadimastem (www.kadimastem.com) is a biotechnology company focused on the industrial development and commercialization of human pluripotent stem cell-based products. At Kadimastem, the pluripotent stem cell technology is used to produce specialized human cells and tissues for two major types of medical applications: 1) Drug-screening platforms using human ...

Beike Biotech Company Limited

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for u...


More From BioPortfolio on "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks